Acurx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of novel antibiotics to treat serious bacterial infections. The company operates primarily in the research and development phase, targeting unmet medical needs in infectious diseases. Acurx's business model involves advancing its proprietary drug candidates through clinical trials, with a focus on addressing antibiotic resistance. The company serves healthcare providers and patients in the pharmaceutical market, primarily in the United States.
